Synonym: VEGF165
Species: Human
Protein Accession: Y04701
Purity: Greater than 95%
Endotoxin Level: Less than 1 EU/µg
Biological Activity: The ED50 as determined by a cell proliferation assay using
human umbilical vein endothelial cells (HUVEC) is less than 1.0 ng/ml.
Expression System: CHO cells
Fusion Tag: None
Predicted Molecular Mass: Approximately 38 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS
Reconstitution: It is recommended to reconstitute the lyophilized VEGF165 in
sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other
aqueous solutions.
Storage & Stability: Lyophilized VEGF165 although stable at room temperature for 3
weeks, should be stored desiccated below -18°C. Upon reconstitution, VEGF165 should be
stored at 4°C between 2-7 days and for future use below -18°C.
FAQ
What is Y04701 Recombinant Human VEGF165, and how does it benefit animal
feed?
Y04701 Recombinant Human VEGF165 is a bioengineered protein that mimics the
Vascular Endothelial Growth Factor (VEGF) found naturally in humans. In the context of
animal feed, this recombinant protein can have multiple benefits. VEGF165 plays a
crucial role in angiogenesis, the formation of new blood vessels from pre-existing ones.
This process is vital for ensuring adequate oxygen and nutrient supply to tissues. When
incorporated into animal feed, VEGF165 can enhance growth performance by improving blood
circulation and nutrient absorption in animals. Improved angiogenesis can lead to better
muscle development, higher rates of weight gain, and overall healthier livestock.
Enhanced blood flow can also aid in waste removal and better immune responses, reducing
disease susceptibility.
How does Y04701 Recombinant Human VEGF165 improve the
health of livestock?
The administration of Y04701 Recombinant Human VEGF165 in
animal feed can significantly improve livestock health through several mechanisms.
First, by promoting angiogenesis, VEGF165 ensures that tissues receive adequate blood
supply, which is essential for the delivery of nutrients and oxygen and the removal of
waste products. This can lead to improved cellular function and overall better health.
Additionally, better vascularization can support more robust immune responses by
facilitating the transport of immune cells to sites of infections or injuries.
Furthermore, enhanced blood flow can help maintain optimal body temperature and improve
metabolism, contributing to well-balanced physiological functions. All these factors
collectively lead to healthier, more resilient livestock, capable of better growth and
higher production yields.
Can Y04701 Recombinant Human VEGF165 be used safely
across different species of livestock?
Yes, Y04701 Recombinant Human VEGF165 can
be safely used across different species of livestock, including poultry, swine, cattle,
and sheep. The protein is designed to be species-agnostic in its angiogenic effects,
making it a versatile additive for various types of animal feed. However, it's essential
to adhere to recommended dosage guidelines specific to each species to ensure maximum
efficacy and safety. Extensive research has shown that VEGF165 has a low toxicity
profile, minimizing the risk of adverse effects when used appropriately. Moreover,
ongoing studies continue to evaluate its safety across multiple species, further
confirming its broad applicability. Veterinarians and animal nutritionists should be
consulted to tailor the optimal dosage and administration strategy for different types
of livestock, ensuring that the benefits are maximized while mitigating any potential
risks.
What are the potential side effects of using Y04701 Recombinant Human
VEGF165 in animal feed?
While Y04701 Recombinant Human VEGF165 has a low toxicity
profile and is generally safe for use in animal feed, there are some potential side
effects to consider. Overdosage or improper administration could lead to excessive
angiogenesis, which might cause abnormal tissue growth and complications such as edema
or unintended vascular issues. In rare cases, there could be hypersensitivity or
allergic reactions, manifesting as skin irritations or gastrointestinal disturbances.
It’s crucial to follow dosage recommendations strictly and consult with a veterinarian
or animal nutritionist for personalized advice tailored to specific livestock needs.
Regular monitoring for any signs of adverse effects during the initial phases of
administration is also advisable. This proactive approach ensures that any potential
issues can be identified and addressed promptly, thereby safeguarding animal health and
optimizing the benefits of Y04701 Recombinant Human VEGF165.
How should Y04701
Recombinant Human VEGF165 be administered in animal feed for optimal results?
For
optimal results, Y04701 Recombinant Human VEGF165 should be precisely dosed and
uniformly mixed into the animal feed. The concentration generally depends on the
specific type of livestock, their age, weight, and health status. It's best to use
automated feed mixing equipment to ensure even distribution of the recombinant protein
throughout the feed, which guarantees that each animal receives a consistent and
effective dose. Liquid formulations can be sprayed onto feed, while powdered forms can
be blended directly. Periodic reassessment is crucial to adjust the dosage based on
growth performance, health status, and specific farm conditions. It's recommended to
start with a lower dose and gradually increase it while monitoring the animals for any
changes in behavior, growth rates, and overall health. Consulting with a veterinarian or
an animal nutritionist can provide additional guidance tailored to your specific
livestock needs, ensuring that Y04701 Recombinant Human VEGF165 delivers maximum
benefits in animal feed.